Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.050

-8.0%

3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (132)	1/11/1999 11:07:00 PM
From: BRAVEHEART	Read Replies (1) of 179

Hi Richard, I recently spoke with PCOP on this agreement. It is a smaller form of collaboration. PCOP only expects it to bring in 1 to 2 million annually. The up side of my conversation included added perspective on the companies status of turning profitable over the next year. An upcoming significant collaboration with a "new" Big Pharma partnership. The fact that the dilution from prior venture capitalists is all but out. The potential dilution from the remaining 5 million shares ( CORNING ) is muted and may not even occur. Finally the patent issue with Affemex is looking more like a negotiable issue based on recent patent rights PCOP has established relative to AFFX position ( One hand washes the other ). Hence I believe this reduced dilution issue along with the positive events forthcoming should result in a good year for PCOP shareholders provided Corning et al remains long. The stock has a little way to go before a breakout can be predicted. But having followed PCOP for close to 2 years I'd say things are looking their best since last Jan. clearstation.com BEST WISHES LONE WOLF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next